APA ציטוט

Kasahara, R., Kawahara, T., Ohtake, S., Saitoh, Y., Tsutsumi, S., Teranishi, J., . . . Uemura, H. (2017). A Low Psoas Muscle Index before Treatment Can Predict a Poorer Prognosis in Advanced Bladder Cancer Patients Who Receive Gemcitabine and Nedaplatin Therapy. Biomed Res Int.

Citação norma Chicago

Kasahara, Ryo, et al. "A Low Psoas Muscle Index Before Treatment Can Predict a Poorer Prognosis in Advanced Bladder Cancer Patients Who Receive Gemcitabine and Nedaplatin Therapy." Biomed Res Int 2017.

ציטוט MLA

Kasahara, Ryo, et al. "A Low Psoas Muscle Index Before Treatment Can Predict a Poorer Prognosis in Advanced Bladder Cancer Patients Who Receive Gemcitabine and Nedaplatin Therapy." Biomed Res Int 2017.